Anticoagulants in the treatment of cancer.
D000721:Ancrod / Q000627:therapeutic use; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D001241:Aspirin / Q000494:pharmacology; D003374:Coumarins / Q000627:therapeutic use; D005176:Factor XIII / Q000037:antagonists & inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D051381:Rats
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D006493:Heparin; D005176:Factor XIII; D000721:Ancrod; D001241:Aspirin